Dolby Family Ventures
Dolby Family Ventures is an early stage venture firm focused on building great technology companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Dolby Family Ventures Information
Geographic Data
Address: 999 Brannan St
City: San Francisco
State: CA
Zip: 94103
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Dolby Family Ventures is an early stage venture firm focused on building great technology companies. They partner with best-in-class innovators and strong investment syndicate partners at the seed stage of a company’s development. Unlike many seed investors, They intend to continue to invest across future rounds in our successful portfolio companies.
Contact Phone:
+14154491005
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2016 | Athira Pharma | Series A | 10M |
| 3/2018 | Atomwise | Series A | 45M |
| 11/2015 | Eyefluence | Series B | 14M |
| 10/2017 | Chirp Microsystems | Seed Round | 500k |
| 2/2021 | Roviero | Seed | 6.6M |
| 11/2022 | Bionaut Labs | Series B | 0 |
| 3/2019 | Kuprion | Series A | 5M |
| 8/2008 | ZOZI | Seed Round | 1.3M |
| 3/2011 | ZOZI | Series B | 10M |
| 4/2022 | DigiLens | Series D | 0 |
| 1/2018 | Tiaki Therapeutics | Seed Round | - |
| 8/2021 | Diamond Age | Seed Round | 0 |
| 12/2019 | Atmosic | Series B | 28.5M |
| 1/2016 | Cortexyme | Series A | 15M |
| 12/2018 | Ultraleap | Series C | 0 |
| 9/2013 | Littlecast | Seed Round | 2M |
| 9/2021 | Delix Therapeutics | Series A | 0 |
| 11/2022 | MedCrypt | Series B | 0 |
| 5/2022 | Ubotica | Seed Round | 0 |
| 4/2020 | Cerevance | Series B | 65M |
| 6/2012 | Tetra Discovery | Grant | 1.5M |
| 8/2017 | Alzeca Biosciences | Series A | 11M |
| 11/2015 | PharmatrophiX | Debt Financing | 10.3M |
| 11/2017 | Envisagenics | Seed Round | 2.4M |
| 11/2017 | Ursa Major | Series A | 8M |
| 7/2015 | Cognition Therapeutics | Series B | 15.8M |
| 11/2021 | Sepion Technologies | Series A | 0 |
| 2/2015 | Mixed Dimensions | Convertible Note | 0 |
| 11/2021 | DigiLens | Series D | - |
| 10/2020 | Sea Machines Robotics | Series B | 0 |
| 9/2020 | Salvia BioElectronics | Series A | 0 |
| 6/2018 | Zebra Medical Vision | Series C | 30M |
| 6/2018 | Vium | Series B | 24M |
| 12/2014 | 3Scan | Series A | 6.7M |
| 6/2015 | Eargo | Series A | 13.6M |
| 9/2015 | Cognition Therapeutics | Series B | 0 |
| 12/2021 | Ursa Major | Series C | 85M |
| 11/2017 | Athira Pharma | Venture Round | 15.2M |
| 6/2014 | Wickr | Series B | 0 |
| 9/2020 | Neuro Therapia | Series A | 0 |
| 6/2014 | Authentic Vision | Venture Round | - |
| 7/2019 | Strateos | Venture Round | 0 |
| 11/2015 | Stellar Labs | Seed Round | 0 |
| 10/2020 | Authentic Vision | Series B | 5M |
| 5/2016 | Zebra Medical Vision | Series B | 12M |
| 5/2020 | QurAlis | Series A | 0 |
| 2/2020 | EnClear Therapies | Series A | 0 |
| 8/2010 | ZOZI | Series A | 3M |
| 5/2021 | Therini Bio | Seed Round | 0 |
| 7/2019 | Therini Bio | Seed Round | 9.3M |
| 1/2021 | CytoVale | Debt Financing | 0 |
| 5/2023 | Genemod | Seed Round | 0 |
| 6/2019 | Lightform | Series A | 0 |
| 8/2017 | Tempo Automation | Series B | 20M |
| 2/2019 | Phylagen | Series A | 0 |
| 10/2013 | BASIS Science | Series B | 23M |
| 10/2014 | Keyssa | Series C | 25M |
| 5/2018 | Phase Four | Seed Round | - |
| 11/2013 | August Home | Series A | 8M |
| 7/2021 | H2U Technologies | Series A | 7M |
| 1/2015 | goBalto | Series C | 0 |
| 11/2016 | Tetra Therapeutics | Series A | 0 |
| 10/2017 | Stellar Labs | Series A | 0 |
| 10/2021 | H2U Technologies | Series A | 0 |
| 3/2017 | Echo | Series A | 7.5M |
| 11/2022 | Cajal Neuroscience | Series A | 96M |
| 2/2016 | Yumanity Therapeutics | Series A | 51M |
| 7/2015 | AltspaceVR | Series A | 10.3M |
| 8/2017 | Mixed Dimensions | Seed Round | 2.6M |
| 1/2023 | Atomos Space | Series A | 16.2M |
| 9/2016 | Podium Data | Series A | 9.7M |
| 5/2017 | Ultraleap | Series B | 23M |
| 2/2023 | Cerevance | Series B | 0 |
| 4/2023 | Therini Bio | Series A | 0 |
| 4/2023 | Mojo Vision | Series C | 0 |
| 6/2018 | Paradromics | Seed Round | 7M |
| 7/2021 | Paradromics | Seed | 20M |
| 11/2021 | Cala Health | Series D | 0 |
| 3/2021 | TripleBlind | Seed Round | 0 |
| 10/2021 | TripleBlind | Series A | 24M |
| 5/2018 | Cortexyme | Series B | 76M |
| 3/2023 | QurAlis | Series B | 0 |
| 9/2020 | Libra Therapeutics | Series A | 29M |
| 1/2022 | Mojo Vision | Series B | 0 |
| 7/2022 | Canaery | Seed Round | 0 |
| 6/2022 | OKAPI:Orbits | Seed Round | 0 |
| 11/2018 | Mojo Vision | Series A | 0 |
| 4/2017 | Cortexyme | Debt Financing | 8M |
| 5/2023 | Paradromics | Series A | 0 |
| 1/2017 | DigiLens | Series B | 22M |
| 4/2020 | Mojo Vision | Series B | 0 |
| 12/2015 | Eargo | Series B | 25M |
| 7/2016 | 3Scan | Series B | 14M |
| 6/2015 | Vium | Series A | 20M |
| 2/2022 | Diamond Age | Series A | 50M |
| 9/2020 | NativeWaves | Seed Round | - |
| 9/2018 | System1 Biosciences | Series A | 25M |
| 8/2020 | Atomwise | Series B | 0 |
| 4/2019 | NativeWaves | Seed Round | - |
| 2/2015 | New Matter | Series A | 6.5M |
| 4/2017 | Athira Pharma | Venture Round | 1.4M |
| 6/2014 | CytoVale | Series A | 4.3M |
| 10/2014 | Cortexyme | Seed Round | 1M |
| 7/2015 | ZOZI | Series C | 0 |
| 6/2011 | ICON Aircraft | Series C | 25M |
| 11/2017 | Lightform | Seed Round | 0 |
| 12/2014 | Beep Networks | Seed Round | 4M |
| 9/2019 | GenomSys | Series A | 9.4M |
| 9/2021 | Acrigen Biosciences | Seed Round | - |
| 7/2022 | Canaery | Seed Round | 0 |
| 6/2022 | OKAPI:Orbits | Seed Round | 0 |
| 5/2022 | Ubotica | Seed Round | 0 |
| 4/2022 | DigiLens | Series D | 0 |
| 2/2022 | Diamond Age | Series A | 0 |
| 1/2022 | Mojo Vision | Series B | 0 |
| 12/2021 | Ursa Major | Series C | 0 |
| 11/2021 | Sepion Technologies | Series A | 0 |
| 11/2021 | Cala Health | Series D | 0 |
| 11/2021 | DigiLens | Series D | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
